A recessive major gene controls the Mitsuda reaction in a region endemic for leprosy

Journal of Infectious Diseases

Volumn 192, Issue 8, 2005, Pages 1475-1482

  Ranque, Brigitte ^a   Alcaïs, Alexandre ^a   Van Thuc, Nguyen ^b   Woynard, Sébastien ^a   Thai, Vu Hong ^b   Huong, Nguyen Thu ^b   Ba, Nguyen Ngoc ^b   Khoa, Pham Xuan ^b   Schurr, Erwin ^c   Abel, Laurent ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hospital for Dermato Venereology   (Viet Nam)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROMIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDEMIC DISEASE; FAMILIAL DISEASE; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GRANULOMATOSIS; HOMOZYGOTE; HUMAN; LEPROSY; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MAJOR GENE; MALE; MITSUDA REACTION; MYCOBACTERIUM LEPRAE; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REGISTER; SEGREGATION ANALYSIS; VIET NAM;

FEMALE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INJECTIONS, INTRADERMAL; LEPROMIN; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MALE; MYCOBACTERIUM LEPRAE; SKIN; VIETNAM;

EID: 25844523877     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/466535     Document Type: Article

References (38)

1. Britton WJ, Lockwood DN. Leprosy. Lancet 2004; 363:1209-19.
2. World Health Organization. Global leprosy situation. Wkly Epidemiol Rec 2005; 80:113-24.
3. Ridley DS, Jopling WH. Classification of leprosy according to immunity, a five-group system. Int J Lepr Other Mycobact Dis 1966; 34: 255-73.
4. Sansonetti P, Lagrange PH. The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis 1981; 3:422-69.
5. Abel L, Lap VD, Oberti J, et al. Complex segregation analysis of leprosy in Southern Vietnam. Genet Epidemiol 1995; 12:63-82.
6. Abel L, Demenais F. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade Island. Am J Hum Genet 1988; 42:256-66.
7. Alcais A, Mira M, Casanova JL, Schurr E, Abel L. Genetic dissection of immunity in human leprosy. Curr Opin Immunol 2005; 17:44-8.
8. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20:581-620.
9. Siddiqui MR, Meisner S, Tosh K, et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001; 27: 439-41.
10. Mira MT, Alcais A, Van Thuc N, et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 2003; 33:412-5.
11. Mira MT, Alcais A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004; 427:636-40.
12. Petri V, Mendes EV, Beiguelman B. Histology of the Mitsuda reaction of healthy adults with no known contacts with leprosy patients. Int J Lepr Other Mycobact Dis 1985; 53:540-5.
13. Chaudhuri S, Hajra SK, Mukherjee A, et al. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons from Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma. Int J Lepr Other Mycobact Dis 1998; 66: 182-9.
14. Lastoria LC, Opromolla DV, Fleury RN, Habermann F, Curi PR. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms. Int J Lepr Other Mycobact Dis 1998; 66: 190-200.
15. Thomas J, Joseph M, Ramanujam K, Chacko CJ, Job CK. The histology of the Mitsuda reaction and its significance. Lepr Rev 1980; 51:329-39.
16. Narayan NP, Ramu G, Desikan KV, Vallishayee RS. Correlation of clinical, histological and immunological features across the leprosy spectrum. Indian J Lepr 2001; 73:329-42.
17. Ilangumaran S, Ramanathan S, Schankernarayan N, Ramu G, Muthukkarauppan V. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens. Int J Lepr Other Mycobact Dis 1996; 64:6-14.
18. Price MA. Cell-mediated immunologic status of healthy members of families with a history of leprosy. Int J Lepr Other Mycobact Dis 1975; 43:307-13.
19. Rotberg A. The "Hansen-anergic fringe." Acta Leprol 1986; 4:347-54.
20. Shah DH, Vartak RR, Naik SS, Dandekar SR, Ganapati R. Epidemiological studies in children of a low-endemic region, a high-endemic region, and dwellers of a leprosy colony: evaluation of anti-ND-BSA antibodies and lepromin response. Int J Lepr Other Mycobact Dis 1994; 62:539-46.
21. Beiguelman B, Guagliato R. Nature and familial character of the lepromin reactions. Int J Lepr 1965; 33:800-7.
22. Feitosa M, Krieger H, Borecki I, Beiguelman B, Rao DC. Genetic epidemiology of the Mitsuda reaction in leprosy. Hum Hered 1996; 46: 32-5.
23. Alcais A, Sanchez FO, Thuc NV, et al. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J Infect Dis 2000; 181:302-8.
24. Vidal S, Malo D. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73:469-85.
25. Bonney GE. On the statistical determination of major gene mechanisms in continuous human traits. Am J Med Genet 1984; 18:731-49.
26. Garcia A, Cot M, Chippaux JP, et al. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am J Trop Med Hyg 1998; 58:480-8.
27. Demenais F, Lathrop M. Use of the regressive models in linkage analysis of quantitative traits. Genet Epidemiol 1993; 10:587-92.
28. Sampogna F, Demenais F, Hochez J, et al. Segregation analysis of IgE levels in 335 French families (EGEA) using different strategies to correct for the ascertainment through a correlated trait (asthma). Genet Epidemiol 2000; 18:128-42.
29. Demenais F, Lathrop GM. REGRESS: a computer program including the regressive approach into the LINKAGE programs. Genet Epidemiol 1994; 11:291.
30. Collins FM, Morrison NE, Watson SR. Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens. Int J Lepr Other Mycobact Dis 1983; 51:481-9.
31. Thuc NV, Abel L, Lap VD, Oberti J, Lagrange PH. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Int J Lepr Other Mycobact Dis 1994; 62:532-8.
32. Souza-Campos N, Leser W, Bechelli LM, Quagliato R, Rotberg A. Viragem da lepromino reacao em funcao de diferentes estimulos. Influencia da idade, nessa virgem, no grupo etario de 6 a 43 meses. Rev Bras Leprol 1962; 29:3-20.
33. Beiguelman B. Leprosy and genetics: a review. Rev Bras Genet 1983; 6:109-72.
34. Paula-Souza R, Bechelli LM. Correlaçao entre as reacoes leprominica e tuberculinica em crianças de 0 a 4 anos. Rev Bras Leprol 1960; 28: 203-10.
35. Amezcua ME, Escobar-Gutierrez A, Barba-Rubio J, et al. Prospective immunological follow-up in household contacts of Mexican leprosy patients. Int J Lepr Other Mycobact Dis 1990; 58:651-9.
36. Dharmendra D. Studies of the lepromin test. The active principle of lepromin is a protein antigen of the bacillus. Leprosy in India 1941; 1941: 89-103.
37. Ott J. Analysis of human genetic linkage. 3rd ed. Baltimore: Johns Hopkins University Press, 1999.
38. Clerget-Darpoux F, Bonaiti-Pellie C, Hochez J. Effects of mispecifying genetic parameters in lod score analysis. Biometrics 1986; 42:393-9.